Drugs / Ku 60019
last change Sep 2024 re-read 2 minutes ago

Ku 60019

Small molecule

Developed for
kidney cancer
Investigated by
University Hospital, Grenoble

Trials 1 · a red edge is where a trial was stopped

201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT03571438 Oct 2017 → Sep 2022 kidney cancer University Hospital, Grenoble Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Ku 60019 “CK2(CX4945) and ATM(Ku 60019)” NCT03571438
Modality Small molecule CHEMBL2140173